Salivary gland dysfunction and xerostomia in Sjögren's syndrome

Oral and Maxillofacial Surgery Clinics of North America

Volumn 26, Issue 1, 2014, Pages 35-53

  Jensen, Siri Beier ^a   Vissink, Arjan ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Hyposalivation; Salivary gland dysfunction; Sialometry; Sj gren's syndrome; Subjective assessment; Xerostomia

Indexed keywords

CHEMISTRY; HUMAN; HYPOSALIVATION; PATHOPHYSIOLOGY; REVIEW; SALIVA; SALIVARY GLAND; SALIVARY GLAND DYSFUNCTION; SECRETION (PROCESS); SIALOMETRY; SJOEGREN SYNDROME; SJÖGREN'S SYNDROME; SUBJECTIVE ASSESSMENT; XEROSTOMIA;

HYPOSALIVATION; SALIVARY GLAND DYSFUNCTION; SIALOMETRY; SJÖGREN'S SYNDROME; SUBJECTIVE ASSESSMENT; XEROSTOMIA;

HUMANS; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 84896972513     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2013.09.003     Document Type: Review

References (41)

1. Veerman E.C., van den Keybus P.A., Vissink A., et al. Human glandular salivas: their separate collection and analysis. Eur J Oral Sci 1996, 104:346-352.
2. Nieuw Amerongen A.V., Bolscher J.G., Veerman E.C. Salivary mucins: protective functions in relation to their diversity. Glycobiology 1995, 5:733-740.
3. Tabak L.A. In defense of the oral cavity: structure, biosynthesis, and function of salivary mucins. Annu Rev Physiol 1995, 57:547-564.
4. DiSabato-Mordarski T., Kleinberg I. Measurement and comparison of the residual saliva on various oral mucosal and dentition surfaces in humans. Arch Oral Biol 1996, 41:655-665.
5. Kalk W.W., Vissink A., Spijkervet F.K., et al. Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 2001, 60:1110-1116.
6. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
7. Pijpe J., Kalk W.W., Bootsma H., et al. Progression of salivary gland dysfunction in patients with Sjögren's syndrome. Ann Rheum Dis 2007, 66:107-112.
8. Pijpe J., Meijer J.M., Bootsma H., et al. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome. Arthritis Rheum 2009, 60:3251-3256.
9. Pijpe J., van Imhoff G.W., Spijkervet F.K., et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005, 52:2740-2750.
10. Hansen A., Lipsky P.E., Dorner T. Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol 2005, 17:558-565.
11. Nguyen C.Q., Hu M.H., Li Y., et al. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum 2008, 58:734-743.
12. Pijpe J., van Imhoff G.W., Vissink A., et al. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjögren's syndrome and associated MALT lymphoma. Ann Rheum Dis 2005, 64:958-960.
13. Youinou P., Devauchelle V., Hutin P., et al. A conspicuous role for B cells In Sjögren's syndrome. Clin Rev Allergy Immunol 2007, 32:231-237.
14. Fox P.C., Busch K.A., Baum B.J. Subjective reports of xerostomia and objective measures of salivary gland performance. JAm Dent Assoc 1987, 115:581-584.
15. Sreebny L.M., Vissink A. Sialometry: the measure of things, with ease and reliability. Dry mouth-the malevolent symptom: a clinical guide 2010, 64-76. Wiley-Blackwell, Ames (IA). 1st edition. L.M. Sreebny, A. Vissink (Eds.).
16. Vissink A., Wolff A., Veerman E.C.I. Saliva collectors. Saliva diagnostics 2008, 37-59. Wiley-Blackwell, Ames (IA). D.T. Wong (Ed.).
17. Navazesh M., Christensen C.M. A comparison of whole mouth resting and stimulated salivary measurement procedures. J Dent Res 1982, 61:1158-1162.
18. Burlage F.R., Pijpe J., Coppes R.P., et al. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci 2005, 113:386-390.
19. Vissink A., Bootsma H., Kroese F.G., et al. How to assess treatment efficacy in Sjögren's syndrome?. Curr Opin Rheumatol 2012, 24:281-289.
20. Hu S., Wang J., Meijer J., et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007, 56:3588-3600.
21. Hu S., Vissink A., Arellano M., et al. Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays. Proteomics 2011, 11:1499-1507.
22. Hu S., Gao K., Pollard R., et al. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res (Hoboken) 2010, 62:1633-1638.
23. Hu S., Zhou M., Jiang J., et al. Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 2009, 60:81-92.
24. Takagi Y., Kimura Y., Nakamura H., et al. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjögren's syndrome?. Ann Rheum Dis 2010, 69:1321-1324.
25. Vitali C., Bootsma H., Bowman S.J., et al. Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 2013, 72:476-478.
26. Bootsma H., Spijkervet F.K., Kroese F.G., et al. Toward new classification criteria for Sjögren's syndrome?. Arthritis Rheum 2013, 65:21-23.
27. Shiboski S.C., Shiboski C.H., Criswell L., et al. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012, 64:475-487.
28. Cornec D., Jousse-Joulin S., Pers J.O., et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward newdiagnostic criteria?. Arthritis Rheum 2013, 65:216-225.
29. Pai S., Ghezzi E.M., Ship J.A. Development of a visualanalogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001, 91:311-316.
30. Ship J.A., Fox P.C., Baum B.J. How much saliva is enough? 'Normal' function defined. JAm Dent Assoc 1991, 122:63-69.
31. Sreebny L.M. Saliva in health and disease: an appraisal and update. Int Dent J 2000, 50:140-161.
32. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. JDent Res 1987, (66 Spec No):648-653.
33. Vissink A., De Jong H.P., Busscher H.J., et al. Wetting properties of human saliva and saliva substitutes. JDent Res 1986, 65:1121-1124.
34. Meijer J.M., Meiners P.M., Huddleston Slater J.J., et al. Health-related quality of life, employment and disability in patients with Sjögren's syndrome. Rheumatology (Oxford) 2009, 48:1077-1082.
35. Belenguer R., Ramos-Casals M., Brito-Zeron P., et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2005, 23:351-356.
36. Barendregt P.J., Visser M.R., Smets E.M., et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998, 57:291-295.
37. Bjerrum K., Prause J.U. Primary Sjögren's syndrome: a subjective description of the disease. Clin Exp Rheumatol 1990, 8:283-288.
38. Tensing E.K., Solovieva S.A., Tervahartiala T., et al. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. Clin Exp Rheumatol 2001, 19:313-316.
39. Schneyer L.H. Source of resting total mixed saliva of man. JAppl Physiol 1956, 9:79-81.
40. Dawes C., Wood C.M. The contribution of oral minor mucous gland secretions to the volume of whole saliva in man. Arch Oral Biol 1973, 18:337-342.
41. Dawes C., Ong B.Y. Circadian rhythms in the flow rate and proportional contribution of parotid to whole saliva volume in man. Arch Oral Biol 1973, 18:1145-1153.